Efficacy of neoadjuvant hyperthermic intraperitoneal chemotherapy in advanced high-grade serous ovarian cancer (the NHIPEC trial): study protocol for a randomised controlled trial

BACKGROUND: Neoadjuvant chemotherapy (NACT) is an important treatment option for patients with ovarian cancer. Although intravenous NACT can improve optimal resection rates and decrease surgical morbidity and mortality, these advantages do not translate into a survival benefit. Ovarian carcinoma is...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Miao-Fang, Wang, Li-Juan, Ye, Yan-Fang, Liu, Chang-Hao, Lu, Huai-Wu, Yao, Ting-Ting, Zhang, Bing-Zhong, Chen, Qing, Li, Ji-Bin, Peng, Yong-Pai, Zhou, Hui, Lin, Zhong-Qiu, Li, Jing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8679100/
https://www.ncbi.nlm.nih.gov/pubmed/34916306
http://dx.doi.org/10.1136/bmjopen-2020-046415

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8679100/
https://www.ncbi.nlm.nih.gov/pubmed/34916306
http://dx.doi.org/10.1136/bmjopen-2020-046415

Ejemplares similares